News - Janssen-Cilag, Markets & Marketing


Popular Filters

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis


The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

5.6% annual growth forecast for multiple myeloma drug market to 2020


Driven by further penetration of Celgene’s Revlimid (lenalidomide) into the first-line setting and…

CelgeneGlobalJanssen-CilagMarkets & MarketingOncologyPharmaceuticalRevlimidTakeda PharmaceuticalsVelcade

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top